New drug combo tested for Tough-to-Treat breast cancers
Disease control
Ongoing
This study is testing a combination of three drugs—cisplatin, romidepsin, and nivolumab—for people with advanced triple-negative breast cancer or breast cancer linked to a BRCA gene mutation. The goal is to see if this combination is safe and can help control the cancer in patien…
Phase: PHASE1, PHASE2 • Sponsor: Priyanka Sharma • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC